U.S. federal trademark · Serial No. 97799503 · Reg. No. 7396297
Research and development in the pharmaceutical and biotechnology fields
antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; antiviral allogeneic cell therapy products in the nature of T cells; antiviral allogeneic cell therapy products in the nature of virus-specific T cells; antiviral cells for medical use; antiviral T cells for medical use; antiviral virus-specific T cells for medical use; antiviral immunotherapeutic agents for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, allogenic T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, virus-specific T cells, for restoring viral immunity in immunocompromised patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.